Rafferty Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Rafferty Asset Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-105,586	Closed	-$9.81M	–	1358
2021 Q4	$9.81M	Buy	105,586 +53,118	+101%	+$3.5M	0.05%	186
2021 Q3	$3.12M	Buy	52,468 +12,455	+31%	+$736K	0.02%	454
2021 Q2	$2.73M	Sell	40,013 -3,210	-7%	-$209K	0.02%	537
2021 Q1	$3M	Buy	43,223 +29,749	+221%	+$2.29M	0.02%	494
2020 Q4	$1.03M	Sell	13,474 -17,836	-57%	-$1.34M	0.01%	486
2020 Q3	$2.34M	Buy	31,310 +15,733	+101%	+$1.05M	0.03%	370
2020 Q2	$981K	Buy	15,577 +10,530	+209%	+$579K	0.01%	551
2020 Q1	$212K	Sell	5,047 -37,921	-88%	-$1.74M	0.01%	513
2019 Q4	$1.95M	Sell	42,968 -57,016	-57%	-$2.7M	0.03%	398
2019 Q3	$4.58M	Buy	99,984 +37,838	+61%	+$2.13M	0.07%	161
2019 Q2	$3.64M	Sell	62,146 -9,098	-13%	-$470K	0.06%	227
2019 Q1	$3.19M	Buy	+71,244	New	+$3.27M	0.05%	207

Rafferty Asset Management's ARNA Position: Q1 2022 in Review

Rafferty Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 105,586 shares — an estimated $9.81M sold.

Rafferty Asset Management first reported a position in ARNA in Q1 2019 and held it in 12 quarters. The position peaked at $9.81M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Rafferty Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Rafferty Asset Management sold 105,586 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $9.81M.
Rafferty Asset Management first reported a position in Arena Pharmaceuticals Inc in Q1 2019 and held it in 12 quarters.
Rafferty Asset Management's Arena Pharmaceuticals Inc position peaked at $9.81M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Rafferty Asset Management's 13F filing for Q1 2022, filed 13 May 2022.